equitybuy

CME · CME Group Inc.

CME Group Inc. operates global contract markets for futures and options. Recent research flags CME as a potential beneficiary if prediction markets and event-style contracts grow, given its scale in listed derivatives and clearing economics.

Opportunity
37 / 100
Current score
0.64
Calls tracked
2
Active plays
2

Recent proof-backed calls

Recent internal coverage referenced discussion of prediction markets and macro signals. Podcast excerpts include Kalshi’s Head of Research on prediction markets and ARK Invest/Cathie Wood discussing macro indicators and a partnership with Kalshi. No direct corporate announcements for CME were cited.

ARK Investyoutuberight

Podcast episode featuring Kalshi’s Head of Research discussing prediction markets and how they could be used for forecasting and risk management. The excerpt provided contains no concrete corporate news, financial results, partnership announcement, regulatory decision, or product launch tied to a publicly traded company—mostly high-level discussion about the prediction-market category and Kalshi’s mission/background.

Mentioned: Apr 11, 2026, 1:49 PM EDTConviction: 34 / 100Return: 8.85%
Source: Kalshi Beats Consensus | The Brainstorm EP 125
ARK Investyoutuberight

Cathie Wood (ARK Invest) discusses macro signals (inflation/jobs/war) and highlights an unexpected divergence between PPI and CPI. The main concrete item is ARK’s announced partnership with Kalshi (a regulated prediction-market platform), framed as a potential catalyst for a broader “financial innovation wave” and new data/signals for markets.

Mentioned: Apr 11, 2026, 1:48 PM EDTConviction: 30 / 100Return: 11.81%
Source: Inflation, Jobs, War: Kalshi’s Signals | ITK With Cathie Wood

Latest market-close explanation

On 2026-04-13 CME closed at $300.59 (+1.79%) on volume down 46.9% versus the prior session, with an intraday range of $295.83–$300.74. Recent coverage also cites a podcast featuring Jason Trennert on market dynamics.

2026-04-13Move: 1.79%Close: $300.59research

**CME** (CME Group Inc.) moved **+1.79%** on 2026-04-13, closing at **$300.59** after a previous close of **$295.30**. Intraday range was **$295.83** to **$300.74**. Volume changed **-46.9%** versus the prior session. Recent internal coverage also touched CME: **Jason Trennert on Populism, Policy & a Distorted Market System | The Real Eisman Playbook Episode 44**.

Current stance

Current recommendation: buy. Rationale: CME is viewed as a potential beneficiary via category optionality — incumbents in listed derivatives could capture second-order benefits if event contracts and prediction-market activity expand.

Recommendationbuy
Authors1
Active plays2
Latest price$300.59
Why now
  • beneficiary via Category optionality: incumbents benefit if prediction markets/event contracts expand under clearer regulation. from https://www.youtube.com/@ARKInvest2015 (confidence 0.34)
  • beneficiary via Prediction markets as an emerging mainstream financial product layer from https://www.youtube.com/@ARKInvest2015 (confidence 0.30)

Top authors on this ticker

Active and historical plays

Active plays highlight scenarios where CME benefits from broader adoption of prediction markets and event-risk trading. Examples: “Kalshi Beats Consensus | The Brainstorm EP 125” and “Inflation, Jobs, War: Kalshi’s Signals | ITK With Cathie Wood.”

Unlock full ticker monitoring

Monitor regulatory developments affecting prediction markets, any product or partnership announcements linking listed-derivatives venues and event contracts, and CME’s trading and clearing volumes for signs of category optionality materializing.